# A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)

> **NCT02416492** · PHASE2 · COMPLETED · sponsor: **SanBio, Inc.** · enrollment: 63 (actual)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **BIOLOGICAL:** SB623 cells
- **PROCEDURE:** Sham Control

## Key facts

- **NCT ID:** NCT02416492
- **Lead sponsor:** SanBio, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-06
- **Primary completion:** 2019-01-31
- **Final completion:** 2019-03-05
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2021-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02416492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02416492, "A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02416492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*